Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,148 | $16,414 | $26,766 | $41,489 |
| - Cash | $10,041 | $9,394 | $11,702 | $16,440 |
| + Debt | $2,196 | $2,328 | $2,191 | $2,254 |
| Enterprise Value | -$3,697 | $9,348 | $17,255 | $27,303 |
| Revenue | $46 | $152 | $165 | $303 |
| % Growth | -69.7% | -7.9% | -45.5% | – |
| Gross Profit | -$15 | -$105 | -$139 | -$83 |
| % Margin | -32.6% | -69.1% | -84.2% | -27.4% |
| EBITDA | -$3,167 | -$3,420 | -$4,107 | -$4,157 |
| % Margin | -6,884.8% | -2,250% | -2,489.1% | -1,371.9% |
| Net Income | -$10,312 | -$3,429 | -$5,794 | -$9,172 |
| % Margin | -22,417.4% | -2,255.9% | -3,511.5% | -3,027.1% |
| EPS Diluted | -1.75 | -0.58 | -0.98 | -1.58 |
| % Growth | -201.7% | 40.8% | 38% | – |
| Operating Cash Flow | -$3,292 | -$2,254 | -$4,163 | -$3,972 |
| Capital Expenditures | -$9 | -$247 | -$331 | -$30 |
| Free Cash Flow | -$3,301 | -$2,501 | -$4,494 | -$4,002 |